List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Fabry Disease Treatment Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Fabry Disease Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Fabry Disease Treatment Market Size for the Year 2017-2028
1.2.2 Global Fabry Disease Treatment Market Size for the Year 2017-2028
1.3 Fabry Disease Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Fabry Disease Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Fabry Disease Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Fabry Disease Treatment Market Dynamics
1.4.1 Fabry Disease Treatment Industry Trends
1.4.2 Fabry Disease Treatment Market Drivers
1.4.3 Fabry Disease Treatment Market Challenges
1.4.4 Fabry Disease Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Fabry Disease Treatment by Type
2.1 Fabry Disease Treatment Market Segment by Type
2.1.1 Enzyme Replacement Therapy (ERT)
2.1.2 Chaperone Treatment
2.1.3 Substrate Reduction Therapy (SRT)
2.1.4 Others
2.2 Global Fabry Disease Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Fabry Disease Treatment Market Size by Type (2017-2028)
2.4 United States Fabry Disease Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Fabry Disease Treatment Market Size by Type (2017-2028)
3 Fabry Disease Treatment by Application
3.1 Fabry Disease Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Fabry Disease Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Fabry Disease Treatment Market Size by Application (2017-2028)
3.4 United States Fabry Disease Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Fabry Disease Treatment Market Size by Application (2017-2028)
4 Global Fabry Disease Treatment Competitor Landscape by Company
4.1 Global Fabry Disease Treatment Market Size by Company
4.1.1 Top Global Fabry Disease Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Fabry Disease Treatment Revenue by Player (2017-2022)
4.2 Global Fabry Disease Treatment Concentration Ratio (CR)
4.2.1 Fabry Disease Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Fabry Disease Treatment in 2021
4.2.3 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Fabry Disease Treatment Headquarters, Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Fabry Disease Treatment Headquarters and Area Served
4.3.2 Global Fabry Disease Treatment Companies Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Fabry Disease Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Fabry Disease Treatment Market Size by Company
4.5.1 Top Fabry Disease Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Fabry Disease Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Fabry Disease Treatment Market Size by Region
5.1 Global Fabry Disease Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Fabry Disease Treatment Market Size by Region (2017-2028)
5.2.1 Global Fabry Disease Treatment Market Size by Region: 2017-2022
5.2.2 Global Fabry Disease Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Fabry Disease Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Fabry Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Fabry Disease Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Fabry Disease Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Fabry Disease Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Fabry Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Fabry Disease Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Fabry Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Fabry Disease Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Fabry Disease Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Sanofi S.A.
7.1.1 Sanofi S.A. Company Details
7.1.2 Sanofi S.A. Business Overview
7.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
7.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2017-2022)
7.1.5 Sanofi S.A. Recent Development
7.2 Takeda
7.2.1 Takeda Company Details
7.2.2 Takeda Business Overview
7.2.3 Takeda Fabry Disease Treatment Introduction
7.2.4 Takeda Revenue in Fabry Disease Treatment Business (2017-2022)
7.2.5 Takeda Recent Development
7.3 Amicus Therapeutics Inc.
7.3.1 Amicus Therapeutics Inc. Company Details
7.3.2 Amicus Therapeutics Inc. Business Overview
7.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
7.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
7.3.5 Amicus Therapeutics Inc. Recent Development
7.4 ISU Abxis Co Ltd.
7.4.1 ISU Abxis Co Ltd. Company Details
7.4.2 ISU Abxis Co Ltd. Business Overview
7.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
7.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
7.4.5 ISU Abxis Co Ltd. Recent Development
7.5 JCR Pharmaceuticals Co Ltd.
7.5.1 JCR Pharmaceuticals Co Ltd. Company Details
7.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
7.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
7.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
7.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
7.6 Protalix Biotherapeutics Inc.
7.6.1 Protalix Biotherapeutics Inc. Company Details
7.6.2 Protalix Biotherapeutics Inc. Business Overview
7.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
7.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
7.6.5 Protalix Biotherapeutics Inc. Recent Development
7.7 Idorsia Pharmaceuticals Ltd.
7.7.1 Idorsia Pharmaceuticals Ltd. Company Details
7.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
7.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
7.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
7.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
7.8 Avrobio Inc.
7.8.1 Avrobio Inc. Company Details
7.8.2 Avrobio Inc. Business Overview
7.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
7.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
7.8.5 Avrobio Inc. Recent Development
7.9 Greenovation Biotech GmbH
7.9.1 Greenovation Biotech GmbH Company Details
7.9.2 Greenovation Biotech GmbH Business Overview
7.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
7.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2017-2022)
7.9.5 Greenovation Biotech GmbH Recent Development
7.10 Moderna Therapeutics Inc.
7.10.1 Moderna Therapeutics Inc. Company Details
7.10.2 Moderna Therapeutics Inc. Business Overview
7.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
7.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
7.10.5 Moderna Therapeutics Inc. Recent Development
7.11 Green Cross Pharma Pte Ltd.
7.11.1 Green Cross Pharma Pte Ltd. Company Details
7.11.2 Green Cross Pharma Pte Ltd. Business Overview
7.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
7.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
7.11.5 Green Cross Pharma Pte Ltd. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
